The Indian pharmaceutical sector showed mixed performance on January 16, 2026, as of around 10 AM IST. Broader market indices traded positively, with the Nifty 50 at approximately 25,752 (+0.34%) and the BSE Sensex at 83,725 (+0.41%). However, the pharma segment underperformed, with the S&P BSE Healthcare index at 43,091.95 (-0.62%).
Individual pharma stocks displayed varied movements, with several posting declines amid sector-wide pressure. Here is a summary of the key pharma stocks based on the provided data (prices in Rs, with percentage changes):
- Aarti Drugs: BSE 387.25 (-0.90%), NSE 389.60 (-0.32%)
- Ajanta Pharma: BSE 2,685.00 (-0.79%), NSE 2,682.30 (-0.89%)
- Alembic Pharma: BSE 783.75 (-0.69%), NSE 781.40 (-1.08%)
- Aurobindo Pharma: BSE 1,191.00 (+0.91%), NSE 1,189.20 (+0.77%)
- Biocon: BSE 382.90 (+1.02%), NSE 382.60 (+0.95%)
- Cipla: BSE 1,382.50 (-3.63%), NSE 1,387.30 (-3.29%) — notable underperformer
- Divis Laboratories: BSE 6,330.00 (-0.42%), NSE 6,327.00 (-0.45%)
- Dr. Reddy’s Lab: BSE 1,187.00 (+0.05%), NSE 1,184.00 (-0.21%)
- Glenmark Pharma: BSE 2,013.95 (+0.12%), NSE 2,015.10 (+0.19%)
- Indoco Remedies: BSE 212.20 (+0.38%), NSE 216.77 (+2.75%)
- Ipca Labs: BSE 1,499.45 (-1.10%), NSE 1,497.00 (-1.32%)
- J.B. Chemicals: BSE 1,893.00 (-0.06%), NSE 1,892.70 (-0.14%)
- Lupin: BSE 2,213.95 (+0.86%), NSE 2,216.10 (+0.92%)
- Mankind Pharma: BSE 2,224.40 (-0.87%), NSE 2,227.30 (-0.76%)
- Natco Pharma: BSE 881.40 (-1.18%), NSE 879.60 (-1.38%)
- Orchid Pharma: BSE 740.25 (+0.91%), NSE 735.00 (-0.99%)
- Panacea Biotec: BSE 392.05 (-0.75%), NSE 391.65 (-0.72%)
- Strides Pharma Science: BSE 928.80 (-1.15%), NSE 934.30 (-0.61%)
- Sudeep Pharma Ltd.: BSE 598.00 (-1.88%), NSE 597.70 (-2.22%)
- Sun Pharma: BSE 1,677.80 (-1.34%), NSE 1,676.30 (-1.43%)
- Torrent Pharma: BSE 3,991.95 (-0.32%), NSE 3,988.50 (-0.38%)
- Wockhardt: BSE 1,402.45 (+0.46%), NSE 1,407.80 (+0.91%)
- Zydus Lifesciences: BSE 881.15 (-0.32%), NSE 882.80 (-0.11%)
Gainers included Aurobindo Pharma, Biocon, Lupin, Indoco Remedies (notably on NSE), Orchid Pharma, and Wockhardt. Decliners were more prominent, led by Cipla, Sudeep Pharma, Sun Pharma, and Natco Pharma.
Note: These are indicative prices as of approximately 10 AM IST on January 16, 2026. Stock prices fluctuate throughout the trading day. For real-time updates, refer to official exchanges (NSE/BSE) or financial platforms.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
